Arvind Kumar Bansal (Arvind K Bansal)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Topics

Attention Deficit Hyperactivity Disorder

Metastatic Breast Cancer

Gas Chromatography Mass Spectrometry

Top Venues

Molecular pharmaceutics

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Parag Roy, Soumalya Chakraborty, Noopur Pandey, Nimmy Kumari, Sourav Chougule, Amrita Chatterjee, Kaberi Chatterjee, Pallab Mandal, Bapi Gorain, Ananta V Dhotre, Arvind Kumar Bansal, Animesh Ghosh
Study on Sulfamethoxazole-Piperazine Salt: A Mechanistic Insight into Simultaneous Improvement of Physicochemical Properties. Molecular pharmaceutics (2023)
Samarth D Thakore, Kaustav Das, Sameer Vishvanath Dalvi, C Malla Reddy, Arvind Kumar Bansal
Microscopic Cracks Modulate Nucleation and Solid-State Crystallization Tendency of Amorphous Celecoxib. Molecular pharmaceutics (2023)
Nimmy Kumari, Parag Roy, Sukanta Roy, Prashantkumar K Parmar, Soumalya Chakraborty, Sourav Das, Noopur Pandey, Anirbandeep Bose, Arvind Kumar Bansal, Animesh Ghosh
Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human Volunteers. Molecular pharmaceutics 19 (5) (2022)
Amanpreet Kaur, Jay Prakash Yadav, Rohit Y Sathe, Vibha Puri, Prasad V Bharatam, Arvind Kumar Bansal
Understanding Poor Milling Behavior of Voriconazole from Crystal Structure and Intermolecular Interactions. Molecular pharmaceutics 19 (3) (2022)
Sumit Mukesh, Prachi Joshi, Arvind Kumar Bansal, Mahesh Chand Kashyap, Sanjay K Mandal, Vasant G Sathe, Abhay T Sangamwar
Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability. Molecular pharmaceutics 18 (6) (2021)
Samarth D Thakore, Junia Akhtar, Ranjna Jain, Amrit Paudel, Arvind Kumar Bansal
Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility. Molecular pharmaceutics 18 (8) (2021)
Chaitali Phadke, Jagadish Sharma, Kunnal Sharma, Arvind Kumar Bansal
Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions. Molecular pharmaceutics 16 (10) (2019)
Moksh Jagia, Ruchi Daptardar, Kinjalben Patel, Arvind Kumar Bansal, Sarsvatkumar Patel
Role of Structure, Microenvironmental pH, and Speciation To Understand the Formation and Properties of Febuxostat Eutectics. Molecular pharmaceutics 16 (11) (2019)
Samarth D Thakore, Aaruti Sood, Arvind Kumar Bansal
Emerging role of primary heterogeneous nucleation in pharmaceutical crystallization. Drug development research 81 (1) (2019)
Dnyaneshwar P Kale, Bharat Ugale, C Mallaiah Nagaraja, Gurudutt Dubey, Prasad V Bharatam, Arvind Kumar Bansal
Molecular Basis of Water Sorption Behavior of Rivaroxaban-Malonic Acid Cocrystal. Molecular pharmaceutics 16 (7) (2019)
Jay Prakash A Yadav, Arvind Kumar Bansal, Sanyog Jain
Molecular Understanding and Implication of Structural Integrity in the Deformation Behavior of Binary Drug-Drug Eutectic Systems. Molecular pharmaceutics 15 (5) (2018)
Milankumar S Jasani, Dnyaneshwar P Kale, Inder Pal Singh, Arvind Kumar Bansal
Influence of Drug-Polymer Interactions on Dissolution of Thermodynamically Highly Unstable Cocrystal. Molecular pharmaceutics 16 (1) (2018)
Jay Prakash A Yadav, Bharat Yadav, Navin Kumar, Arvind Kumar Bansal, Sanyog Jain
Revealing the Role of Structural Features in Bulk Mechanical Performance of Ternary Molecular Solids of Isoniazid. Molecular pharmaceutics 15 (11) (2018)
Jayprakash A Yadav, Kailas S Khomane, Sameer R Modi, Bharat Ugale, Ram Naresh Yadav, C M Nagaraja, Navin Kumar, Arvind Kumar Bansal
Correlating Single Crystal Structure, Nanomechanical, and Bulk Compaction Behavior of Febuxostat Polymorphs. Molecular pharmaceutics 14 (3) (2017)